MCID: ANG011
MIFTS: 44

Angiodysplasia malady

Categories: Gastrointestinal diseases, Cardiovascular diseases

Aliases & Classifications for Angiodysplasia

About this section

Aliases & Descriptions for Angiodysplasia:

Name: Angiodysplasia 11 13 48 37 66
Angiodysplasia of Stomach and Duodenum with Hemorrhage 11
 
Angiodysplasia of Colon 66

Classifications:



External Ids:

Disease Ontology11 DOID:2494
ICD9CM30 537.83
SNOMED-CT60 71072006
MeSH37 D016888
ICD1028 K55.2

Summaries for Angiodysplasia

About this section
Wikipedia:69 In medicine (gastroenterology), angiodysplasia is a small vascular malformation of the gut. It is a... more...

MalaCards based summary: Angiodysplasia, also known as angiodysplasia of stomach and duodenum with hemorrhage, is related to angiodysplasia of intestine and nevada syndrome. An important gene associated with Angiodysplasia is VWF (Von Willebrand Factor), and among its related pathways are Cell adhesion_Plasmin signaling and Endochondral Ossification. Affiliated tissues include colon, small intestine and liver, and related mouse phenotypes are digestive/alimentary and homeostasis/metabolism.

Disease Ontology:11 A vascular disease that is characterized as a small vascular malformation of the gut.

Related Diseases for Angiodysplasia

About this section

Diseases related to Angiodysplasia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 125)
idRelated DiseaseScoreTop Affiliating Genes
1angiodysplasia of intestine11.9
2nevada syndrome10.9
3angioosteohypotrophic syndrome10.9
4leydig cell tumor10.5VEGFA, VWF
5larynx carcinoma in situ10.5VEGFA, VWF
6colorectal adenoma10.5FGF2, VEGFA
7ischemic heart disease10.4VEGFA, VWF
8acute bilateral depigmentation of the iris10.4FGF2, VEGFA
9gastric small cell carcinoma10.4FGF2, VEGFA
10vitreous abscess10.4FGF2, VEGFA
11aicardi-goutieres syndrome10.4SST, VEGFA
12naegeli-franceschetti-jadassohn syndrome/dermatopathia pigmentosa reticularis10.4FGF2, VEGFA
13lethal congenital contractural syndrome 210.4SST, VEGFA
14tollner horst manzke syndrome10.4FGF2, VEGFA
15epidural abscess10.4FGF2, VEGFA
16aggressive systemic mastocytosis10.4FGF2, SCT
17neuronal ceroid lipofuscinosis10.3SCT, SST
18diabetes mellitus, transient neonatal, 310.3SCT, SST
19central nervous system germ cell tumor10.3SST, VWF
20localized epiphyseal dysplasia10.3FGF2, VEGFA
21pancreatic cystadenocarcinoma10.3SCT, SST
22peripheral epithelioid sarcoma10.3SCT, SST
23carcinoma of the vocal tract10.3SST, VEGFA
24primary progressive multiple sclerosis10.3SCT, SST
25pancreatic gastrinoma10.3SCT, SST
26migraine with aura10.3SCT, SST
27glucosidase acid-1,4-alpha deficiency10.3SCT, SST
28opportunistic mycosis10.3FGF2, VEGFA
29ferguson-smith tumor10.3SCT, SST
30dermatitis10.3SST, VEGFA
31angina pectoris10.3VEGFA, VWF
32lung carcinoma in situ10.3FGF2, VEGFA
33spinal cord astrocytoma10.3ENG, VEGFA
34placental choriocarcinoma10.3FGF2, VEGFA
35cerebral artery occlusion10.3FGF2, VEGFA
36laryngeal carcinoma10.2SCT, SST
37bubonic plague10.2SST, VEGFA
38von willebrand disease10.2
39partial of retinal vein occlusion10.2FGF2, SST
40nodular degeneration of cornea10.2FGF2, VEGFA
41perinephritis10.2ENG, FGF2
42stoll alembik finck syndrome10.2ACVRL1, ENG
43vhl-related pheochromocytoma10.2ACVRL1, ENG
44lung adenoid cystic carcinoma10.1ENG, FGF2
45renal fibrosis10.1FGF2, VEGFA, VWF
46homocystinuria caused by cystathionine beta-synthase deficiency10.1ACVRL1, ENG
47adrenal rest tumor10.1FGF2, VEGFA, VWF
48prolactin producing pituitary tumor10.1FGF2, SST
49preeclampsia/eclampsia 110.1ENG, VEGFA
50dental pulp disease10.0FGF2, VEGFA

Graphical network of the top 20 diseases related to Angiodysplasia:



Diseases related to angiodysplasia

Symptoms for Angiodysplasia

About this section

Drugs & Therapeutics for Angiodysplasia

About this section

Drugs for Angiodysplasia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 8)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
IronPhase 4, Phase 2, Phase 310807439-89-623925
Synonyms:
02583_FLUKA
12310_ALDRICH
12310_RIEDEL
129048-51-7
14067-02-8
161135-39-3
190454-13-8
195161-83-2
199281-22-6
209309_ALDRICH
209309_SIAL
255637_ALDRICH
266213_ALDRICH
266256_ALDRICH
267945_ALDRICH
267953_ALDRICH
26Fe
338141_ALDRICH
356808_ALDRICH
356824_ALDRICH
356832_ALDRICH
39344-71-3
3ZhP
413054_ALDRICH
443783-52-6
44890_ALDRICH
44890_FLUKA
675141-17-0
70884-35-4
73135-38-3
7439-89-6
8011-79-8
8053-60-9
AC1L2N38
ATW 230
ATW 432
Ancor B
Ancor en 80/150
Armco iron
Atomel 28
Atomel 300M200
Atomel 500M
Atomel 95
Atomiron 44MR
Atomiron 5M
Atomiron AFP 25
Atomiron AFP 5
C00023
C3518_SIAL
C3518_SIGMA
CCRIS 1580
CHEBI:18248
CID23925
Carbonyl iron
Copy Powder CS 105-175
D007501
DB01592
DSP 1000
DSP 128B
DSP 135
DSP 135C
DSP 138
Diseases (animal), iron overload
Diseases, iron overload
EF 1000
EF 250
EFV 200/300
EFV 250
EFV 250/400
EINECS 231-096-4
 
Ed-In-Sol
Eisen
Electrolytic iron
F 60 (metal)
FE
FT 3 (element)
Fe
Fe-40
Fe1+
Feronate
Ferretts
Ferro-Caps
Ferro-Time
Ferrousal
Ferrovac E
Ferrum
Ferrum metallicum
GS 6
HF 2 (element)
HL (iron)
HQ (metal)
HS (iron)
HS 4849
HSDB 604
Hemocyte
Hierro
Hoeganaes ATW 230
Hoeganaes EH
IRMM524A_FLUKA
IRMM524B_FLUKA
IRON
Iron (Fe)
Iron (Fe1+)
Iron ion (Fe+)
Iron ion(1+)
Iron monocation
Iron powder
Iron standard for AAS
Iron(1+)
Iron(1+) ion
Iron(III) nitrate solution
Iron, carbonyl
Iron, electrolytic
Iron, elemental
Iron, ion (Fe1+)
Iron, ion (Fe1+) (8CI,9CI)
Iron, reduced
LOHA
LS-3196
MolPort-003-925-001
NC 100
PZh-1M3
PZh-2
PZh1M1
PZh2M
PZh2M1
PZh2M2
PZh3
PZh3M
PZh4M
PZhO
Reduced iron
Remko
SUY-B 2
Siderol
UNII-E1UOL152H7
Vitedyn-Slo
Yieronia
fer
ferrous iron
hierro
2
Proton pump inhibitorsPhase 2, Phase 31057
Synonyms:
 
PPIs
3
SomatostatinPhase 2, Phase 321238916-34-6, 51110-01-153481605
Synonyms:
growth hormone-inhibiting hormone (GHIH)
 
somatotropin release-inhibiting factor (SRIF)
somatotropin release-inhibiting hormone
4
OctreotidePhase 2, Phase 320683150-76-9383414, 6400441
Synonyms:
(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
10-(4-Aminobutyl)-19-((2-amino-3-phenylpropanoyl)amino)-16-benzyl-7-(1-hydroxyethyl)-N-(2-hydroxy-1-(hydroxymethyl)propyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaa
10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-N-(1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
79517-01-4 (acetate salt)
83150-76-9
AC1L1GVU
AC1L8LCD
AC1L9M4X
C07306
C5H12O2.C4H10
CHEBI:427278
CHEBI:611465
CHEMBL1680
CID383414
CID448601
CID54374
D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-L-threoninol cyclic (2-7)-disulfide
D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl)-L-cysteinamide cyclic (2-7)-disulfide
D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl)-L-cysteinamide cyclic (2->7)-disulfide
D00442
DRG-0115
HMS2090C09
HS-2020
 
L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L- threonyl-N-(2-hydroxy-1-(hydroxymethyl)propyl)-, cyclic (2->7)-disulfide, (R-(R*
L000453
LS-177735
LS-187135
Longastatin
NCGC00181796-01
NCI60_025753
Octreotida
Octreotida [Spanish]
Octreotide
Octreotide (USAN/INN)
Octreotide Acetate Salt
Octreotide [USAN:INN:BAN]
Octreotide-LAR
Octreotidum
Octreotidum [Latin]
Octrotide
SAN 201-995
SM 201-995
SMS 201-995
SMS-201-995
Sandostatine
Sandoz 201-995
UNII-RWM8CCW8GP
nchembio.184-comp3
zacycloicosane-4-carboxamide acetate
5
ThalidomidePhase 2, Phase 1106050-35-15426
Synonyms:
( inverted question mark)-Thalidomide
(+)-Thalidomide
(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide
(+-)-Thalidomide
(+/-)-THALIDOMIDE
(?)-Thalidomide
(±)-N-(2,6-dioxo-3-piperidyl)phthalimide
(±)-thalidomide
.alpha.-(N-Phthalimido)glutarimide
.alpha.-N-Phthalylglutaramide
.alpha.-Phthalimidoglutarimide
1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline
14088-68-7
2,6-Dioxo-3-phthalimidopiperidine
2,6-dioxo-3-phthalimidopiperidine
3-Phthalimidoglutarimide
50-35-1
731-40-8
AB00052362
AC-917
AC1L1KBZ
AC1Q6FJA
AI3-50606
Algosediv
Asidon 3
Asmadion
Asmaval
BPBio1_000159
BRD-A93255169-001-06-9
BRN 0030233
BSPBio_000143
BSPBio_001156
BSPBio_003330
Bio1_000387
Bio1_000876
Bio1_001365
Bio2_000418
Bio2_000898
Bonbrain
Bonbrrin
C07910
C13H10N2O4
CCRIS 8148
CHEBI:105028
CHEMBL468
CID5426
CPD000058524
Calmore
Calmorex
Celgene Brand of Thalidomide
Contergan
Corronarobetin
D00754
D013792
DB01041
Distaval
Distaxal
Distoval
DivK1c_000051
E-217
EINECS 200-031-1
ENMD 0995
EU-0101224
Ectiluran
Enterosediv
Gastrinide
Glupan
Glutanon
Grippex
HMS1362J17
HMS1568H05
HMS1792J17
HMS1922E12
HMS1990J17
HMS2090O05
HMS2093G15
HMS500C13
HSDB 3586
Hippuzon
I06-0197
IDI1_000051
IDI1_002173
IN1061
Imida-Lab
Imida-lab
Imidan
Imidan (peyta)
Imidene
Isomin
K 17
K-17
KBio1_000051
KBio2_000496
KBio2_002322
KBio2_003064
KBio2_004890
KBio2_005632
KBio2_007458
KBio3_000911
KBio3_000912
KBio3_002550
KBio3_002802
KBioGR_000496
KBioGR_001474
KBioGR_002322
KBioSS_000496
KBioSS_002324
Kedavon
Kevadon
LS-109463
LS-140
Lopac0_001224
Lulamin
MLS000069353
MolPort-003-665-582
N-(2,6-Dioxo-3-piperidyl)phthalimide
N-(2,6-dioxo-3-piperidyl)phthalimide
N-Phthalimidoglutamic acid imide
N-Phthaloylglutamimide
N-Phthalyl-glutaminsaeure-imid
N-Phthalyl-glutaminsaeure-imid [German]
N-Phthalylglutamic acid imide
NCGC00015989-03
NCGC00015989-13
NCGC00024708-02
 
NCGC00024708-03
NCGC00024708-04
NCGC00024708-05
NCGC00024708-06
NCGC00024708-07
NCGC00024708-08
NCGC00024708-09
NCI60_023904
NCIOpen2_003188
NINDS_000051
NSC 527179
NSC-66847
NSC527179
NSC66847
NSC91729
NSC91730
Neaufatin
Neo
Neosedyn
Neosydyn
Nerosedyn
Neufatin
Neurodyn
Neurosedin
Neurosedym
Neurosedyn
Nevrodyn
Nibrol
Noctosediv
Noxodyn
Pangul
Pantosediv
Poly-Giron
Polygripan
Predni-Sediv
Prestwick0_000192
Prestwick1_000192
Prestwick2_000192
Prestwick3_000192
Prestwick_463
Pro-Bam M
Pro-ban M
Profarmil
Psycholiquid
Psychotablets
Quetimid
Quietoplex
S1193_Selleck
SAM002564245
SMR000058524
SPBio_000893
SPBio_002064
SPECTRUM1503607
ST51039042
Sandormin
Sedalis
Sedalis sedi-lab
Sedimide
Sedin
Sedisperil
Sedoval
Shin-naito S
Shinnibrol
Sleepan
Slipro
Softenil
Softenon
Spectrum2_000707
Spectrum3_001715
Spectrum4_001087
Spectrum5_001791
Synovir
T144_SIGMA
T150_SIGMA
T151_SIGMA
THALIDOMIDE (AIDS INITIATIVE)
Talargan
Talidomida
Talidomida [INN-Spanish]
Talidomide
Talidomide [DCIT]
Talimol
Talismol
Talizer
Telagan
Telargan
Telargean
Tensival
Thaled
Thaled (TN)
Thalidomide
Thalidomide (+ and -)
Thalidomide (JAN/USP/INN)
Thalidomide (soluble form)
Thalidomide Celgene
Thalidomide Pharmion
Thalidomide [USAN:INN:BAN]
Thalidomidum
Thalidomidum [INN-Latin]
Thalidomine USP26
Thalin
Thalinette
Thalomid
Thalomid (TM)
Thalomid (TN)
Thalomid, Thalidomide
Thalomide
Theophilcholine
UNII-4Z8R6ORS6L
UPCMLD-DP139
UPCMLD-DP139:001
Valgis
Valgraine
WLN: T56 BVNVJ C- DT6VMVTJ
WLN: T56 BVNVJ C- DT6VMVTJ -D
WLN: T56 BVNVJ C- DT6VMVTJ -L
Yodomin
alpha-(N-Phthalimido)glutarimide
alpha-N-Phthalylglutaramide
alpha-Phthalimidoglutarimide
alpha-phthalimidoglutarimide
cMAP_000022
thalidomide
α-(N-phthalimido)glutarimide
α-N-phthalylglutaramide
α-phthalimidoglutarimide
6PomalidomidePhase 111419171-19-8
7
infliximab364170277-31-3
Synonyms:
 
Ig gamma-1 chain C region
Remicade
8COLANutraceutical1824

Interventional clinical trials:

(show all 12)
idNameStatusNCT IDPhase
1Capsule Endoscopy vs Standard of Care for Obscure Intestinal BleedingRecruitingNCT00694954Phase 4
2Endoscopic Band Ligation Versus Argon Plasma Coagulation for the Treatment of Gastric Antral Vascular Ectasia: a Randomized Clinical TrialCompletedNCT01601639Phase 3
3Cyrotherapy vs. APC in GAVECompletedNCT00587405Phase 2, Phase 3
4Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anaemia Due to Small Bowel AngiodysplasiasRecruitingNCT02384122Phase 2, Phase 3
5Pasireotide for the Treatment of Gastrointestinal Angiodysplasia in Endoscopic Treatment FailureCompletedNCT02622906Phase 2
6Long-term Effects of Thalidomide for Recurrent Gastrointestinal Bleeding Due to Vascular MalformationCompletedNCT00964496Phase 2
7Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal BleedingCompletedNCT00389935Phase 2
8Efficacy Study of Thalidomide in Gastrointestinal Vascular Malformation Related BleedingWithdrawnNCT02754960Phase 2
9Pomalidomide in Hereditary Hemorrhagic Telangiectasia and Transfusion-Dependent Vascular Ectasia: a Phase I StudyNot yet recruitingNCT02287558Phase 1
10Prospective Comparison of the Diagnostic Yield of Small Bowel Pillcam SB2 and Capsocam CapsuleCompletedNCT01820182
11Study of Hemospray for Lower Gastrointestinal HemorrhageRecruitingNCT02099435
12Prophylactic Elective Clipping of Colonic DiverticulaRecruitingNCT02094456

Search NIH Clinical Center for Angiodysplasia


Cochrane evidence based reviews: angiodysplasia

Genetic Tests for Angiodysplasia

About this section

Anatomical Context for Angiodysplasia

About this section

MalaCards organs/tissues related to Angiodysplasia:

34
Colon, Small intestine, Liver, Endothelial, Lung, Bone, Appendix

Animal Models for Angiodysplasia or affiliated genes

About this section

MGI Mouse Phenotypes related to Angiodysplasia:

39
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053818.2ACVRL1, ENG, SST, VEGFA, VWF
2MP:00053766.8ACVRL1, CADPS, ENG, FGF2, SST, VEGFA
3MP:00107686.7ACVRL1, CADPS, ENG, FGF2, SST, VEGFA
4MP:00036316.5ACVRL1, CADPS, ENG, FGF2, SST, VEGFA

Publications for Angiodysplasia

About this section

Articles related to Angiodysplasia:

(show top 50)    (show all 438)
idTitleAuthorsYear
1
Popliteal Artery Entrapment and Fibular Angiodysplasia in Siblings. (27480046)
2016
2
Analysis of risk factor and clinical characteristics of angiodysplasia presenting as upper gastrointestinal bleeding. (26828247)
2016
3
Use of polymethylmethacrylate in treatment of arteriovenous angiodysplasia with bone lesions. (26355937)
2015
4
Successful treatment of thalidomide for recurrent bleeding due to gastric angiodysplasia in hereditary hemorrhagic telangiectasia. (23661527)
2013
5
Colonic vascular ectasia (angiodysplasia) in a juvenile dog. (23058126)
2013
6
Combined endoclipping and argon plasma coagulation (APC)--daisy technique for cecal angiodysplasia. (24285060)
2013
7
Von Willebrand disease-associated angiodysplasia: a few answers, still many questions. (23432086)
2013
8
Multiple intestinal atresias associated with angiodysplasia in a newborn. (21763851)
2011
9
Intestinal angiodysplasia and aortic valve stenosis: let's not close the book on this association. (19216082)
2009
10
The mechanisms of thalidomide in treatment of angiodysplasia due to hypoxia]. (19576118)
2009
11
A pseudotumoral angiodysplasia. (19544268)
2009
12
Diffuse colorectal angiodysplasia misdiagnosed preoperatively as ulcerative colitis in a child: report of a case. (18668317)
2008
13
Von Willebrand disease and angiodysplasia responding to atorvastatin. (18510690)
2008
14
Long-term follow-up of patients with small-bowel angiodysplasia on capsule endoscopy. Determinants of a higher clinical impact and rebleeding rate. (18563976)
2008
15
Long-term efficacy of octreotide in the prevention of recurrent bleeding from gastrointestinal angiodysplasia. (17311647)
2007
16
Long-term outcome of argon plasma ablation therapy for bleeding in 100 consecutive patients with colonic angiodysplasia. (17024322)
2006
17
Successful colectomy for the treatment of repetitive bleeding from colonic angiodysplasia in a patient with Heyde syndrome. (16617184)
2006
18
Endoscopic detachable mini-loop ligation for treatment of gastroduodenal angiodysplasia: case study of 11 patients with long-term follow-up. (14997147)
2004
19
Angiodysplasia as a cause of gastrointestinal bleeding in childhood. (14747971)
2004
20
Radiology case of the month. Hematochezia in an unstable patient. Acute lower gastrointestinal hemorrhage secondary to angiodysplasia. (15688667)
2004
21
Somatostatin therapy ameliorates chronic and refractory gastrointestinal bleeding caused by diffuse angiodysplasia in a patient on anticoagulation therapy. (12889571)
2003
22
Pedunculated angiodysplasia of the colon successfully treated with endoscopy: a new type of angiodysplasia. (12665782)
2003
23
Selective angiographic catheterisation for jejunal angiodysplasia. (11222835)
2001
24
Migrating site of bleeding in a right colon demonstrating angio-dysplasia following a segmental resection of the colon. A unique variant of angiodysplasia. (11124566)
2000
25
Multiple jejunal angiodysplasia detected by enema-helical CT. (11124471)
2000
26
Type 2B von Willebrand's disease and angiodysplasia. (10595657)
1999
27
Transjugular intrahepatic portosystemic shunt for bleeding angiodysplasia-like lesions in portal-hypertensive colopathy. (9649472)
1998
28
Angiodysplasia in the renal patient: how to diagnose and how to treat? (9761492)
1998
29
Angiodysplasia, haemostasis and capillaries. A hypothesis. (8948067)
1996
30
Angiodysplasia of the colon in children. (7722835)
1995
31
Octreotide in the treatment of bleeding due to angiodysplasia of the small intestine. (8362842)
1993
32
Angiodysplasia of the gastrointestinal tract. (8389094)
1993
33
Aortic stenosis and bleeding gastrointestinal angiodysplasia: is acquired von Willebrand's disease the link? (1351610)
1992
34
Does hormonal therapy have any benefit for bleeding angiodysplasia? (1328358)
1992
35
Hormonal therapy for bleeding from angiodysplasia: chronic renal failure, et al?? (2252035)
1990
36
A rare case of angiodysplasia: penetration of inguinal lymph nodes by large superficial leg veins. Report of five cases. (2114699)
1990
37
Endoscopic treatment of colonic angiodysplasia: the procedure was a success, but.... (2323528)
1990
38
Jejunal angiodysplasia presenting as intestinal perforation. (2756994)
1989
39
Angiodysplasia--an uncommon cause of colonic bleeding: colonoscopic evaluation of 1,050 patients with rectal bleeding and anaemia. (3500991)
1987
40
Angiodysplasia in a colonic polyp. (3706089)
1986
41
Aortic stenosis associated with angiodysplasia. (2870037)
1986
42
Cecal angiodysplasia localized by 99mtechnetium blood-pool scintigraphy and specimen venography. (3011267)
1986
43
Renal failure and angiodysplasia of the colon. (3873889)
1985
44
Small intestinal angiodysplasia in the elderly. (6332839)
1984
45
Angiodysplasia. Clinical presentation and colonoscopic diagnosis. (6609803)
1984
46
Plain radiographic, nuclear medicine and angiographic observations of hepatogenic pulmonary angiodysplasia. (6223268)
1983
47
Radiologic analysis of bone structure in congenital angiodysplasia. (7341252)
1981
48
Congenital angiodysplasia with skeletal affection. (7368842)
1980
49
Endoscopic appearance of gastric angiodysplasia in hereditary hemorrhagic telangiectasia. (6967258)
1980
50
Caecal angiodysplasia as a cause of chronic iron deficiency anaemia: a case report. (7403971)
1980

Variations for Angiodysplasia

About this section

Expression for genes affiliated with Angiodysplasia

About this section
Search GEO for disease gene expression data for Angiodysplasia.

Pathways for genes affiliated with Angiodysplasia

About this section

GO Terms for genes affiliated with Angiodysplasia

About this section

Cellular components related to Angiodysplasia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1platelet alpha granule lumenGO:003109310.4VEGFA, VWF
2extracellular spaceGO:00056158.1ENG, FGF2, SCT, SST, VEGFA
3extracellular regionGO:00055768.1FGF2, SCT, SST, VEGFA, VWF

Biological processes related to Angiodysplasia according to GeneCards Suite gene sharing:

(show all 22)
idNameGO IDScoreTop Affiliating Genes
1cell migration involved in sprouting angiogenesisGO:000204210.3FGF2, VEGFA
2positive regulation of blood vessel endothelial cell migrationGO:004353610.3FGF2, VEGFA
3positive regulation of endothelial cell migrationGO:001059510.2FGF2, VEGFA
4positive regulation of cell divisionGO:005178110.2FGF2, VEGFA
5positive chemotaxisGO:005091810.1FGF2, VEGFA
6endocardial cushion to mesenchymal transitionGO:009050010.1ACVRL1, ENG
7artery morphogenesisGO:004884410.0ENG, VEGFA
8positive regulation of MAP kinase activityGO:00434069.9FGF2, VEGFA
9endocardial cushion morphogenesisGO:00032039.9ACVRL1, ENG
10vasculogenesisGO:00015709.9ENG, VEGFA
11positive regulation of epithelial cell proliferationGO:00506799.8FGF2, VEGFA
12negative regulation of blood vessel endothelial cell migrationGO:00435379.8ACVRL1, FGF2
13patterning of blood vesselsGO:00015699.8ENG, VEGFA
14positive regulation of BMP signaling pathwayGO:00305139.8ACVRL1, ENG
15positive regulation of pathway-restricted SMAD protein phosphorylationGO:00108629.8ACVRL1, ENG
16dorsal aorta morphogenesisGO:00359129.6ACVRL1, ENG
17positive regulation of endothelial cell proliferationGO:00019389.6ACVRL1, FGF2, VEGFA
18positive regulation of protein phosphorylationGO:00019349.5ENG, FGF2, VEGFA
19positive regulation of gene expressionGO:00106289.0ENG, FGF2, VEGFA
20positive regulation of angiogenesisGO:00457668.9ACVRL1, ENG, FGF2, VEGFA
21angiogenesisGO:00015258.8ACVRL1, ENG, FGF2, VEGFA
22positive regulation of transcription from RNA polymerase II promoterGO:00459448.5ACVRL1, ENG, FGF2, VEGFA

Molecular functions related to Angiodysplasia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1chemoattractant activityGO:00420569.6FGF2, VEGFA
2activin bindingGO:00481859.6ACVRL1, ENG
3transforming growth factor beta bindingGO:00504319.0ACVRL1, ENG

Sources for Angiodysplasia

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
25GTR
26HGMD
27HMDB
28ICD10
29ICD10 via Orphanet
30ICD9CM
31IUPHAR
32KEGG
35MedGen
37MeSH
38MESH via Orphanet
39MGI
42NCI
43NCIt
44NDF-RT
47NINDS
48Novoseek
50OMIM
51OMIM via Orphanet
55PubMed
56QIAGEN
61SNOMED-CT via Orphanet
65Tumor Gene Family of Databases
66UMLS
67UMLS via Orphanet